Gracell Biotechnologies Inc.: share_based_compensation
| Value | {"amount": 3494000, "concept": "us-gaap:ShareBasedCompensation", "currency": "USD"} |
|---|---|
| Period | 2022-01-01 – 2022-12-31 |
| Status | current |
| Entity | Gracell Biotechnologies Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:23:15.844735+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/ab8b6372-74d7-40c0-b6b8-0afe941218e3
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001104659-23-049599Retrieved: 2026-08-19T18:23:15.844735+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001826492/share-based-compensation/2022-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/ab8b6372-74d7-40c0-b6b8-0afe941218e3
History
- supersedes {"unit": "CNY", "value": 24102000, "concept": "us-gaap:ShareBasedCompensation"} (evidence 0001104659-23-049599)